Celine Halioua

Background

Celine Halioua is the founder and CEO of Loyal, a clinical-stage animal health company in San Francisco.

Loyal develops lifespan extension drugs for dogs and raised $100 million in a Series C round led by age1.

Key facts

Current title

CEO, Loyalsource

Company founded

Late 2019source

Series C

$100 million, led by age1source

Series B

$45 million, led by Bain Capital Venturessource

WYDE coverage of Celine Halioua

Sources

• Loyal's LOY-002 Clears Two of Three FDA Longevity Drug Gates | WYDE Newsroom
• Loyal: $100 Million Series C Raised To Advance First Canine Longevity Drug | Pulse 2.0
• Gunderson Dettmer Advises Loyal in its $45M Series B Financing | Gunderson Dettmer